Association between low-grade albuminuria and hearing impairment in a non-diabetic Korean population: The Korea National Health and Nutrition Examination Survey (2011–2013)

References

• Wallhagen MI, Strawbridge WJ, Cohen RD, Kaplan GA. An increasing prevalence of hearing impairment and associated risk factors over three decades of the Alameda Country Study. Am J Public Health. 1997;87:440–2.
   PubMed Web of Science ®Google Scholar
• Lin FR, Yaffe K, Xia J, Xue QL, Harris TB, Purchase-Helzner E, et al. Hearing loss and cognitive decline in older adults. JAMA Intern Med. 2013;173:293–9.
   PubMed Web of Science ®Google Scholar
• Walling AD, Dickson GM. Hearing loss in older adults. Am Fam Physician. 2012;85:1150–6.
   PubMed Web of Science ®Google Scholar
• Rosen S, Olin P. Hearing loss and coronary heart disease. Arch Otolaryngol. 1965;82:236–43.
   PubMed Web of Science ®Google Scholar
• Gates GA, Cobb JL, D’Agostino RB, Wolf PA. The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg. 1993;119:156–61.
   PubMed Web of Science ®Google Scholar
• Shargorodsky J, Curhan SG, Eavey R, Curhan GC. A prospective study of cardiovasulcar risk factors and incident hearing loss in men. Laryngoscope. 2010;120:1887–91.
   PubMed Web of Science ®Google Scholar
• Kang SH, Jung da J, Cho KH, Park JW, Yoon KW, Do JY. The association between metabolic syndrome or chronic kidney disease and hearing thresholds in Koreans: the Korean National Health and Nutrition Examination Survey 2009-2012. PLoS One. 2015;10:e0120372.
   PubMed Web of Science ®Google Scholar
• Bigazzi R, Bianchi S, Baldari D. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens. 1998;16:1325–33.
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286;421–6.
   PubMed Web of Science ®Google Scholar
• Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P. Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345:870–8.
   PubMed Web of Science ®Google Scholar
• Malik AR, Sultan S, Turner ST, Kullo IJ. Urinary albumin excretion is associated with impaired flow- and nitroglycerin-mediated brachial artery dilatation in hypertensive adults. J Hum Hypertens. 2007;21:231–8.
   PubMed Web of Science ®Google Scholar
• van der Velde M, Halbesma N, de Charro FT, Bakker SJ, de Zeeuw D, de Jong PE, et al. Screening for albuminuria identifies individuals at increased renal risk. J Am Soc Nephrol. 2009;20:852–62.
   PubMed Web of Science ®Google Scholar
• Klausen KP, Parving HH, Scharling H, Jensen JS. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. J Intern Med. 2007;262:470–8.
   PubMed Web of Science ®Google Scholar
• Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol. 2004;33:189–98.
   PubMed Web of Science ®Google Scholar
• Danziger J. Importance of low-grade albuminuria. Mayo Clin Proc. 2008;83:806–12.
   PubMed Web of Science ®Google Scholar
• Huang Y, Chen Y, Xu M, Gu W, Bi Y, Li X, et al. Low-grade albuminuria is associated with carotid intima-media thickness in Chinese type 2 diabetic patients. J Clin Endocrinol Metab. 2010;95:5122–8.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen Y, Xu Y, Li M, Wang T, Xu B, et al. Low-grade albuminuria is associated with metabolic syndrome and its components in middle aged and elderly Chinese population. PLoS One. 2013;8:e65597.
   PubMed Web of Science ®Google Scholar
• Katz DH, Selvaraj S, Aguilar FG, Martinez EE, Beussink L, Kim KY, et al. Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study. Circulation. 2014;129:42–50.
   PubMed Web of Science ®Google Scholar
• Hong JW, Ku CR, Noh JH, Ko KS, Rhee BD, Kim DJ. Association between low-grade albuminuria and cardiovascular risk in Korean adults: the 2011-2012 Korean National Health and Nutrition Examination Survey. PLoS One. 2015;10:e0118866.
   Google Scholar
• Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777–82.
   PubMed Web of Science ®Google Scholar
• Klausen KP, Scharling H, Jensen G, Jensen JS. New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Hypertension. 2005;46:33–7.
   PubMed Web of Science ®Google Scholar
• Ingelsson E, Sundstrom J, Lind L, Riserus U, Larsson A, Basu S, et al. Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men. Eur Heart J. 2007;28:1739–45.
   PubMed Web of Science ®Google Scholar
• Park SY, Park YK, Cho KH, Choi HJ, Han JH, Han KD, et al. Normal range albuminuria and metabolic syndrome in South Korea: the 2011-2012 Korean National Health and Nutrition Examination Survey. PLoS One. 2015;10:e0125615.
   Google Scholar
• Dalton DS, Cruickshanks KJ, Klein R, Klein BE, Wiley TL. Association of NIDDM and hearing loss. Diabetes Care. 1998;21:1540–4.
   PubMed Web of Science ®Google Scholar
• Bainbridge KE, Cheng YJ, Cowie CC. Potential mediators of diabetes-related hearing impairment in the U.S. population: National Health and Nutrition Examination Survey 1999-2004. Diabetes Care. 2010;33:811–16.
   PubMed Web of Science ®Google Scholar
• Shen FC, Hsieh CJ. Severity of hearing impairment is positively associated with urine albumin excretion rate in patients with type 2 diabetes. J Diabetes Investig. 2014;5:743–7.
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999:130:461–70.
   PubMed Web of Science ®Google Scholar
• Rehm J, Room R, Monteiro M, Gmel G, Graham K, Rehn N, et al. Alcohol use. In: Ezzati M, Lopez A, Rodgers A, Murray CJL, eds. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors, pp. 9591108. Geneva: World Health Organization, 2004.
   Google Scholar
• The Korea Centers for Disease Control and Prevention: Alcohol drinking. [internet]. Available from: http://health.mw.go.kr/HealthPromotionArea/HealthInfo/View.do?idx= 5800 &subIdx = 3&searchCate=&searchType=&searchKey=&pageNo = 1
   Google Scholar
• Kim J, Chu SK, Kim K, Moon JR. Alcohol use behaviors and risk of metabolic syndrome in South Korean middle-aged men. BMC Public Health. 2011;11:489.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnostic and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.
   PubMed Web of Science ®Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421.
   PubMed Web of Science ®Google Scholar
• Suka M, Sugimori H, Yoshida K. Application of the updated Framingham risk score to Japanese men. Hypertens Res. 2001;24:685–9.
   PubMed Web of Science ®Google Scholar
• Selvarajah S, Kaur G, Haniff J, Cheong KC, Hiong TG, van der Graaf Y, et al. Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population. Int J Cardiol. 2014;176:211–18.
   PubMed Web of Science ®Google Scholar
• Chia YC, Gray SY, Ching SM, Lim HM, Chinna K. Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study. BMJ Open. 2015;5:e007324.
   Web of Science ®Google Scholar
• Kang JW, Choi HS, Kim K, Choi JY. Dietary vitamin intake correlates with hearing thresholds in the older population: the Korean National Health and Nutrition Examination Survey. Am J Clin Nutr. 2014;99:1407–13.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D’Agostino RB, et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation. 2005;111:1370–6.
   PubMed Web of Science ®Google Scholar
• Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112:969–75.
   PubMed Web of Science ®Google Scholar
• Hederstierna C, Hultcrantz M, Collins A, Rosenhall U. Hearing in women at menopause. Prevalence of hearing loss, audiometric configuration and relation to hormone replacement therapy. Acta Otolaryngol. 2007;127:149–55.
   PubMed Web of Science ®Google Scholar
• Hwang JH, Hsu CJ, Liu TC, Yang WS. Association of plasma adiponectin levels with hearing thresholds in adults. Clin Endocrinol. 2011;75:614–20.
   PubMed Web of Science ®Google Scholar